Eli Lilly Boosts Q1 2026 Earnings, Expands into Vaccines with $3.8 B Acquisition

Eli Lilly and Company (NYSE: LLY) announced its first‑quarter 2026 results on April 30, 2026. Worldwide revenue rose 5...

Read story →